检索结果 - Paul M. Moseley

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

    Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuv... 由 T. M. A. Abdel-Fatah, Christina J. Perry, P. Dickinson, Graham Ball, Paul M. Moseley, Srinivasan Madhusudan, Ian O. Ellis, Stephen Chan

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells

    Ataxia Telangiectasia Mutated and Rad3 Related (ATR) Protein Kinase Inhibition Is Synthetically Lethal in XRCC1 Deficient Ovarian Cancer Cells 由 Rebeka Sultana, Tarek M.A. Abdel-Fatah, Christina J. Perry, Paul M. Moseley, Nada Albarakti, Vivek Chandra mohan, Claire Seedhouse, Stephen Chan, Srinivasan Madhusudan

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers

    ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers 由 Tarek M.A. Abdel-Fatah, Arvind Arora, Paul M. Moseley, Clare Coveney, Christina J. Perry, Kerstie Johnson, Christopher Kent, Graham Ball, Stephen Chan, Srinivasan Madhusudan

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast Cancer

    Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse... 由 Gemma A. Foulds, Jayakumar Vadakekolathu, Tarek M.A. Abdel-Fatah, Divya Nagarajan, Stephen Reeder, Catherine Johnson, Simon Hood, Paul M. Moseley, Stephen Chan, A. Graham Pockley, Sergio Rutella, Stéphanie McArdle

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer

    Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer 由 Arvind Arora, Tarek M. Abdel-Fatah, Devika Agarwal, Rachel Doherty, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Alaa T. Alshareeda, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Srinivasan Madhusudan

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis

    SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis 由 Tarek M.A. Abdel-Fatah, Devika Agarwal, Dongxu Liu, Roslin Russell, Oscar M. Rueda, Karen Liu, Bing Xu, Paul M. Moseley, Andrew R. Green, A. Graham Pockley, Robert C. Rees, Carlos Caldas, Ian O. Ellis, Graham Ball, Stephen Chan

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer

    Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer 由 Tarek M.A. Abdel-Fatah, Fiona K. Middleton, Arvind Arora, Devika Agarwal, Tao Chen, Paul M. Moseley, Christina J. Perry, Rachel Doherty, Stephen Chan, Andrew R. Green, Emad A. Rakha, Graham Ball, Ian O. Ellis, Nicola J. Curtin, Srinivasan Madhusudan

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy

    Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy 由 Nada Albarakati, Tarek M.A. Abdel-Fatah, Rachel Doherty, Roslin Russell, Devika Agarwal, Paul M. Moseley, Christina J. Perry, Arvind Arora, Nouf H. Alsubhi, Claire Seedhouse, Emad A. Rakha, Andrew R. Green, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, Srinivasan Madhusudan

    出版 2014
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    <scp>RECQL4</scp> helicase has oncogenic potential in sporadic breast cancers

    <scp>RECQL4</scp> helicase has oncogenic potential in sporadic breast cancers 由 Arvind Arora, Devika Agarwal, Tarek MA Abdel‐Fatah, Huiming Lu, Deborah L. Croteau, Paul M. Moseley, Mohammed A. Aleskandarany, Andrew R. Green, Graham Ball, Emad A. Rakha, Stephen Chan, Ian O. Ellis, Lisa L. Wang, Yongliang Zhao, Adayabalam S. Balajee, Vilhelm A. Bohr, Srinivasan Madhusudan

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer

    Evaluation of CDK12 Protein Expression as a Potential Novel Biomarker for DNA Damage Response–Targeted Therapies in Breast Cancer 由 Kalnisha Naidoo, Patty T. Wai, Sarah Maguire, Frances Daley, Syed Haider, Divya Kriplani, James Campbell, Hasan Mirza, Anita Grigoriadis, Andrew Tutt, Paul M. Moseley, Tarek M.A. Abdel-Fatah, Stephen Chan, Srinivasan Madhusudan, Emad A. Rhaka, Ian O. Ellis, Christopher J. Lord, Yinyin Yuan, Andrew R. Green, Rachael Natrajan

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer

    Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer 由 Tarek M. Abdel-Fatah, Roslin Russell, Nada Albarakati, David J. Maloney, Dorjbal Dorjsuren, Oscar M. Rueda, Paul M. Moseley, Vivek Mohan, Hongmao Sun, Rachel Abbotts, Abhik Mukherjee, Devika Agarwal, Jennifer L. Illuzzi, Ajit Jadhav, Anton Simeonov, Graham Ball, Stephen Chan, Carlos Caldas, Ian O. Ellis, David M. Wilson, Srinivasan Madhusudan

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: